Haubold, Johannes http://orcid.org/0000-0003-4843-5911
Zensen, Sebastian
Hosch, René
Schaarschmidt, Benedikt Michael
Bos, Denise
Schmidt, Bernhardt
Flohr, Thomas
Li, Yan
Forsting, Michael
Pietsch, Hubertus
Nensa, Felix
Jost, Gregor
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (FU 356/12-1, FU 356/12-1)
Universitätsklinikum Essen
Article History
Received: 5 October 2022
Accepted: 16 February 2023
First Online: 26 April 2023
Declarations
:
: The animals were handled in compliance with the German Animal Welfare Legislation and with the approval of the State Animal Welfare Committee.
: Not applicable.
: H. Pietsch and G. Jost are employees of Bayer AG. B. Schmidt and T. Flohr are employees of Siemens Healthcare GmbH. The study was performed in cooperation with Bayer AG. Johannes Haubold and Denise Bos received financial support by the German Research Foundation (DFG)-funded Clinician Scientist Academy of the University Hospital Essen (UMEA) (FU 356/12–1). Johannes Haubold has received a speaker honorarium from Siemens Healthineers, Boston Scientific, and Novo Nordisk Pharma GmbH outside of the submitted work. The other authors declare that they have no competing interests.